Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haoxi Health Technology (HAO) Receivables (2023 - 2025)

Haoxi Health Technology's Receivables history spans 3 years, with the latest figure at -$1.0 million for Q4 2025.

  • Quarterly Receivables fell 207.75% to -$1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.0 million through Dec 2025, down 207.75% year-over-year, with the annual reading at $729196.0 for FY2025, 48.76% up from the prior year.
  • Receivables came in at -$1.0 million for Q4 2025, down from $729196.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $953839.0 in Q4 2024 to a low of -$1.0 million in Q4 2025.
  • The 3-year median for Receivables is $490192.0 (2024), against an average of $230636.2.
  • Year-over-year, Receivables skyrocketed 6226.69% in 2024 and then plummeted 207.75% in 2025.
  • Haoxi Health Technology's Receivables stood at $7748.0 in 2023, then soared by 12210.78% to $953839.0 in 2024, then tumbled by 207.75% to -$1.0 million in 2025.
  • Per Business Quant, the three most recent readings for HAO's Receivables are -$1.0 million (Q4 2025), $729196.0 (Q2 2025), and $953839.0 (Q4 2024).